Danaher Corporation (NYSE:DHR) had its price objective boosted by Credit Suisse Group from $93.00 to $96.00 in a research report issued on Friday. The brokerage presently has an “outperform” rating on the conglomerate’s stock. Credit Suisse Group’s price target points to a potential upside of 5.74% from the stock’s current price.

A number of other equities analysts also recently commented on the stock. J P Morgan Chase & Co restated an “overweight” rating and set a $95.00 price objective on shares of Danaher Corporation in a research report on Friday, September 8th. BidaskClub downgraded shares of Danaher Corporation from a “hold” rating to a “sell” rating in a research report on Saturday, July 8th. Wells Fargo & Co restated a “market perform” rating on shares of Danaher Corporation in a research report on Saturday, July 22nd. Citigroup Inc. set a $96.00 price objective on shares of Danaher Corporation and gave the stock a “buy” rating in a research report on Friday, July 21st. Finally, Zacks Investment Research upgraded shares of Danaher Corporation from a “hold” rating to a “buy” rating and set a $97.00 price objective for the company in a research report on Thursday, October 5th. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating, twelve have assigned a buy rating and one has assigned a strong buy rating to the company. Danaher Corporation presently has an average rating of “Buy” and a consensus price target of $93.05.

Danaher Corporation (NYSE:DHR) traded up 0.77% during mid-day trading on Friday, reaching $90.79. 4,063,274 shares of the company traded hands. Danaher Corporation has a 52 week low of $76.27 and a 52 week high of $91.64. The stock’s 50 day moving average price is $86.38 and its 200 day moving average price is $84.25. The firm has a market capitalization of $63.07 billion, a price-to-earnings ratio of 28.98 and a beta of 1.03.

Danaher Corporation (NYSE:DHR) last announced its quarterly earnings data on Thursday, October 19th. The conglomerate reported $1.00 EPS for the quarter, topping the Zacks’ consensus estimate of $0.95 by $0.05. The company had revenue of $4.53 billion during the quarter, compared to the consensus estimate of $4.47 billion. Danaher Corporation had a net margin of 12.63% and a return on equity of 11.15%. Danaher Corporation’s quarterly revenue was up 9.6% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.87 EPS. Equities analysts forecast that Danaher Corporation will post $3.97 EPS for the current year.

ILLEGAL ACTIVITY NOTICE: This report was posted by American Banking News and is the sole property of of American Banking News. If you are accessing this report on another site, it was copied illegally and reposted in violation of international trademark and copyright law. The correct version of this report can be read at https://www.americanbankingnews.com/2017/10/20/danaher-corporations-dhr-buy-rating-reaffirmed-at-credit-suisse-group.html.

In related news, insider Thomas Patrick Joyce, Jr. sold 9,772 shares of the stock in a transaction dated Monday, July 31st. The shares were sold at an average price of $81.78, for a total value of $799,154.16. Following the sale, the insider now directly owns 155,520 shares of the company’s stock, valued at approximately $12,718,425.60. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Also, insider William King sold 43,688 shares of the stock in a transaction dated Thursday, August 31st. The shares were sold at an average price of $82.86, for a total transaction of $3,619,987.68. Following the completion of the sale, the insider now directly owns 45,748 shares in the company, valued at $3,790,679.28. The disclosure for this sale can be found here. 12.20% of the stock is currently owned by corporate insiders.

Several institutional investors have recently added to or reduced their stakes in DHR. GQG Partners LLC acquired a new stake in shares of Danaher Corporation during the 2nd quarter worth about $101,000. Peddock Capital Advisors LLC boosted its stake in shares of Danaher Corporation by 17.4% during the 1st quarter. Peddock Capital Advisors LLC now owns 1,224 shares of the conglomerate’s stock worth $105,000 after purchasing an additional 181 shares during the last quarter. Proficio Capital Partners LLC boosted its stake in shares of Danaher Corporation by 92.3% during the 1st quarter. Proficio Capital Partners LLC now owns 1,246 shares of the conglomerate’s stock worth $105,000 after purchasing an additional 598 shares during the last quarter. Monetary Management Group Inc. boosted its stake in shares of Danaher Corporation by 10.7% during the 2nd quarter. Monetary Management Group Inc. now owns 1,550 shares of the conglomerate’s stock worth $131,000 after purchasing an additional 150 shares during the last quarter. Finally, Acrospire Investment Management LLC boosted its stake in shares of Danaher Corporation by 185.5% during the 2nd quarter. Acrospire Investment Management LLC now owns 1,693 shares of the conglomerate’s stock worth $143,000 after purchasing an additional 1,100 shares during the last quarter. 75.66% of the stock is currently owned by institutional investors.

About Danaher Corporation

Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.

Analyst Recommendations for Danaher Corporation (NYSE:DHR)

Receive News & Ratings for Danaher Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher Corporation and related companies with MarketBeat.com's FREE daily email newsletter.